Coronavirus / COVID

Stay on top of coronavirus news from March 24, 2020.

High-dose intravenous immunoglobulin appeared to reverse deteriorating courses of COVID-19 in 3 case reports from Wuhan, China.

A new study is providing more information on the link between cardiac injury and mortality among patients hospitalized with COVID-19.

This is not the first infectious challenge society has faced, and nor will it be the last.

From epidemiology to treatment modalities, this is very much a learn-as-we-go situation.

The FDA has issued a safety alert on the potential risk of transmitting SARS-CoV-2, the virus that causes coronavirus diseases 2019 (COVID-19), through fecal microbiota transplantation.

Stay up to date with the latest COVID-19 news from Contagion.

Investigations in the US and China make a case for using convalescent plasma, a “last resort” for SARS, as an early treatment for COVID-19.

A new serological assay was developed by a microbiology lab at the Icahn School of Medicine at Mount Sinai.

From PPE shortages to scared staff, what are hospitals currently facing and how can they respond?

The analysis included countries around the world, but the investigators also classified the data by WHO region.

Stay up to date with the latest COVID-19 news from Contagion.

Jason Pogue, PharmD, BCPS, BCIDP, shares his thoughts on a study published in the International Journal of Antimicrobial Agents.

Contagion is partnering with PER to host a live CME-Certified webinar on what clinicians need to know about COVID-19.

The impact of COVID-19 on cardiovascular health is an urgent question for clinicians around the world during this global pandemic.

A Central Science report from the CAS division of the American Chemical Society details developments and recommends directions against COVID-19 pandemic.

Countries around the world have struggled to keep the spread of COVID-19 in check. In countries with relatively few resources and weak public health infrastructure, the challenge is even more acute.

What does it look like when a health system switches from 'containment' to 'mitigation'?

Older people in low-income countries are especially at risk for COVID-19.

The European Union is rethinking its approach to border crossings as the region deals with the COVID-19 pandemic.

FDA grants emergency use authorization for Cepheid's point-of-care COVID-19 diagnostic, Xpert Xpress SARS-CoV-2.

Saskia v. Popescu, PhD, MPH, MA, CIC, a senior infection prevention epidemiologist in Phoenix, Arizona, discusses what it’s like for these frontline fighters and what we can do to “flatten the curve.”

Lopinavir-ritonavir worked against SARS, but it had little effect against coronavirus compared to standard care.

Stay on top of coronavirus developments from March 20, 2020.

New analyses of the novel coronavirus and previously circulating SARS viruses reveal promising immunologic targets for vaccine against COVID-19.